Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Arlington Dermatology | Researchclopedia

Back to institutions

Arlington Dermatology

Arlington Heights, Illinoishealthcare

95

Works

1,979

Citations

21

h-index

Top Research Topics

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Health Systems, Economic Evaluations, Quality of Life

Top Researchers

Amin Kassam Northwest Community Hospital

542 works26,895 citationsh-index: 82

Recent Research

Efficacy and Safety of Risankizumab in Pediatric Patients With Psoriasis: Results From the OptIMMize-1 Phase 3 Study

Nina Magnolo,Lara Wine Lee,et al.

20260 citations

Pharmaceutical studies and practices

Dermatologic Treatments and Research

Nail Diseases and Treatments

Autoimmune Bullous Skin Diseases

Asthma and respiratory diseases

Acne and Rosacea Treatments and Effects

Shoulder Injury and Treatment

Skin Protection and Aging

melanin and skin pigmentation

Mark A. Olson Brigham Young University

245 works8,838 citationsh-index: 55

Angela Moore Baylor University Medical Center

148 works3,390 citationsh-index: 29

Monique R. Bernsen Erasmus MC

116 works3,268 citationsh-index: 30

Tom R. Norris American School Health Association

56 works3,140 citationsh-index: 24

Leonard F. Koziol IS practice

116 works2,605 citationsh-index: 16

Pregnancy and Stroke: Insight From the Cosmos Database

Mohammad Anadani,Lina Hamoud,et al.

20260 citations

Improving neonatology staffing – a practical toolkit to advocate for improvements to clinical staffing

Jieun David,Christiane E.L. Dammann,et al.

20250 citations

Le lébrikizumab améliore les démangeaisons/douleurs cutanées et l’interférence des démangeaisons sur le sommeil chez les patients adultes/adolescents atteints de dermatite atopique modérée à sévère avec peau foncée à la semaine 16 (étude ADmirable)

D. Staumont‐Sallé,A. Alexis,et al.

20250 citations

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks

Andrew Alexis,Michael Bukhalo,et al.

20250 citations

Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study

Kim Papp,Shahram Jacobs,et al.

20252 citations